Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 63, pseudogene (RNU6-63P) is a processed pseudogene in the human genome that shares sequence similarity with the functional U6 small nuclear RNA (snRNA) genes (such as RNU6-1), which are critical components of the spliceosome—a large ribonucleoprotein complex essential for pre-mRNA splicing[1][5]. However, as a pseudogene, RNU6-63P does not encode a functional snRNA product and is not transcribed into a stable or active RNA involved in splicing or any other cellular process[1][5]. Consequently, it has no known biological functions, disease associations, or pharmacological relevance. RNU6-63P is not considered a therapeutic target, nor does it interact with drugs or serve as a biomarker. The entry reflects a non-functional genomic element rather than a protein, receptor, enzyme, or therapeutically actionable nucleic acid.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 63, pseudogene (RNU6-63P).